Form 8-K - Current report:
SEC Accession No. 0001213900-25-036845
Filing Date
2025-04-29
Accepted
2025-04-29 16:42:17
Documents
16
Period of Report
2025-04-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0240038-8k_rafael.htm   iXBRL 8-K 20480
2 PRESS RELEASE, DATED APRIL 29, 2025 ea024003801ex99-1_rafael.htm EX-99.1 14378
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2871
  Complete submission text file 0001213900-25-036845.txt   277178

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rfl-20250429.xsd EX-101.SCH 3777
5 XBRL DEFINITION FILE rfl-20250429_def.xml EX-101.DEF 26617
6 XBRL LABEL FILE rfl-20250429_lab.xml EX-101.LAB 36669
7 XBRL PRESENTATION FILE rfl-20250429_pre.xml EX-101.PRE 25241
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0240038-8k_rafael_htm.xml XML 5666
Mailing Address 520 BROAD STREET NEWARK NJ 07120
Business Address 520 BROAD STREET NEWARK NJ 07120 212-658-1450
Rafael Holdings, Inc. (Filer) CIK: 0001713863 (see all company filings)

EIN.: 822296593 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-38411 | Film No.: 25888557
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)